Skip to ContentSkip to Navigation
About usNews and EventsNews articles

Applying and extending mixed-effects models in health economics and outcomes research

18 December 2012

PhD ceremony: Mr. P. Pechlivanoglou, 9.00 uur, Academiegebouw, Broerstraat 5, Groningen

Dissertation: Applying and extending mixed-effects models in health economics and outcomes research

Promotor(s): prof. M.J. Postma, prof. J.E. Wieringa

Faculty: Mathematics and Natural Sciences

The thesis of Petros Pechlivanoglou examined applications and methodological improvements of mixed-effects models in health-economics and outcomes research. It focused on aspects related to the analysis of prescription-level data and to evidence synthesis. Pechlivanoglou found that mixed-effects models can improve our estimation of effectiveness and cost-effectiveness, as illustrated by a number of treatment options and health-policy decisions. Yet, as indicated in his thesis, improvements in the modeling aspects are still possible. His findings include that the newer agents for prevention of fungal infections in neutropenic patients and of stroke in patients with atrial fibrillation are more effective and potentially more cost-effective than current options. Additionally, educating physicians to think in a cost-effective way, when prescribing, seems to be more effective than financially incentivizing them to do so.

Prescription-level data from the northern Netherlands were analyzed by Pechlivanoglou to identify the probability of a prescription’s generic substitution from the pharmacist. The multilevel, crossed structure of the data required the use of a mixed-effects model, which revealed significant relations between substitution and experience with drug use, pharmacy status and timing. A time-series prescription dataset from the same region was also used to assess the impact of a financial and an educational intervention on rational prescribing. A multivariate state-space model was designed for this analysis. The model identified a significant impact of the educational intervention while the financial incentive was estimated not to have a significant effect on prescribing patterns.

Mixed-effects models were also applied for evidence synthesis to assist medical and health economic decision-making in infectious diseases and stroke prevention. A meta-regression, conducted to synthesize estimates of S. pneumoniae prevalence in community-acquired pneumonia in Europe, identified and incorporated significant regional and healthcare-specific variation across estimates from different studies and countries. Evidence on antifungal prophylaxis as well as on stroke prevention were synthesized and combined with economic decision models to examine the cost-effectiveness of new antifungals and anticoagulants, respectively. The latter study directly influenced Dutch health-care policy through the Health Council. Finally, an improvement on the methodology of network evidence synthesis was done, facilitating application of mixed-effects models in complex model structures.

Last modified:15 September 2017 3.41 p.m.
printView this page in: Nederlands

More news

  • 16 July 2019

    Thirteen Veni grants for young Groningen researchers

    Thirteen researchers from the University of Groningen (UG) and the UMCG have been awarded Veni grants within the framework of NWO’s Innovational Research Incentives Scheme. A terrific result building on last year's successes, where 12 Groningen researchers...

  • 11 July 2019

    UG to build new observatory in dark Lauwersmeer Region

    The Kapteyn Astronomical Institute of the University of Groningen is working on a concrete plan for a new observatory in the Dark Sky Park Lauwersmeer. The observatory will be placed at the Lauwersnest Activity Centre of Staatsbosbeheer in Lauwersoog...

  • 11 July 2019

    Major companies’ annual reports too vague about climate impact

    Many major Dutch companies publish extensive information about climate impact in their annual reports. However, very few companies provide concrete, detailed information about their own CO2 emissions, the impact of climate change on their business...